NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN

Slides:



Advertisements
Similar presentations
Volume 133, Issue 1, Pages (July 2007)
Advertisements

Volume 19, Issue 9, Pages (September 2017)
Volume 133, Issue 1, Pages (July 2007)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 36, Issue 5, Pages (December 2009)
Volume 41, Issue 5, Pages (March 2011)
Volume 33, Issue 2, Pages (January 2009)
Histone Demethylase LSD2 Acts as an E3 Ubiquitin Ligase and Inhibits Cancer Cell Growth through Promoting Proteasomal Degradation of OGT  Yi Yang, Xiaotong.
DEPTOR, an mTOR Inhibitor, Is a Physiological Substrate of SCFβTrCP E3 Ubiquitin Ligase and Regulates Survival and Autophagy  Yongchao Zhao, Xiufang Xiong,
Volume 22, Issue 3, Pages (May 2006)
Volume 134, Issue 2, Pages (July 2008)
Volume 28, Issue 3, Pages (September 2015)
Ubiquitination Regulates PTEN Nuclear Import and Tumor Suppression
Yu-Hsin Chiu, Jennifer Y. Lee, Lewis C. Cantley  Molecular Cell 
The C-terminus of Hsp70-Interacting Protein Promotes Met Receptor Degradation  Kang Won Jang, PhD, Jeong Eun Lee, MD, Sun Young Kim, MD, Min-Woong Kang,
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Volume 18, Issue 8, Pages (February 2017)
Volume 138, Issue 5, Pages e2 (May 2010)
DBC1 Functions as a Tumor Suppressor by Regulating p53 Stability
p53 Stabilization and Transactivation by a von Hippel-Lindau Protein
Volume 19, Issue 6, Pages (September 2005)
Oliver I. Fregoso, Shipra Das, Martin Akerman, Adrian R. Krainer 
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Volume 16, Issue 3, Pages (September 2009)
Volume 130, Issue 4, Pages (August 2007)
Volume 19, Issue 9, Pages (September 2017)
Volume 10, Issue 3, Pages (September 2009)
PARP1 Represses PAP and Inhibits Polyadenylation during Heat Shock
Volume 55, Issue 4, Pages (August 2014)
MAGE-RING Protein Complexes Comprise a Family of E3 Ubiquitin Ligases
Volume 29, Issue 4, Pages (February 2008)
Volume 9, Issue 5, Pages (May 2006)
Volume 14, Issue 5, Pages (November 2008)
Volume 118, Issue 1, Pages (July 2004)
Volume 34, Issue 4, Pages (May 2009)
Volume 13, Issue 1, Pages (January 2008)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Activated Cdc42 Sequesters c-Cbl and Prevents EGF Receptor Degradation
Volume 124, Issue 2, Pages (January 2006)
Lysine 63 Polyubiquitination of the Nerve Growth Factor Receptor TrkA Directs Internalization and Signaling  Thangiah Geetha, Jianxiong Jiang, Marie W.
A Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability
Volume 59, Issue 6, Pages (September 2015)
Volume 19, Issue 6, Pages (September 2005)
Volume 26, Issue 6, Pages (June 2007)
Volume 14, Issue 1, Pages (July 2008)
Volume 7, Issue 3, Pages (May 2014)
Volume 15, Issue 4, Pages (April 2009)
Stress-Induced Phosphorylation of S
TopBP1 Activates the ATR-ATRIP Complex
Volume 21, Issue 6, Pages (November 2017)
Volume 25, Issue 5, Pages (March 2007)
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
Volume 18, Issue 5, Pages (May 2005)
Volume 117, Issue 7, Pages (June 2004)
Volume 125, Issue 4, Pages (May 2006)
Volume 47, Issue 3, Pages (August 2012)
Volume 5, Issue 6, Pages (December 2013)
USP15 Negatively Regulates Nrf2 through Deubiquitination of Keap1
Volume 12, Issue 5, Pages (November 2003)
Volume 21, Issue 9, Pages (November 2017)
Proteasome-Mediated Degradation of p21 via N-Terminal Ubiquitinylation
Dong Zhang, Kathrin Zaugg, Tak W. Mak, Stephen J. Elledge  Cell 
Volume 29, Issue 4, Pages (February 2008)
The Tumor Suppressor PP2A Aβ Regulates the RalA GTPase
Oliver I. Fregoso, Shipra Das, Martin Akerman, Adrian R. Krainer 
Volume 3, Issue 3, Pages (March 2013)
Volume 26, Issue 12, Pages e4 (March 2019)
Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κB  Wei-Chien Huang, Tsai-Kai Ju, Mien-Chie.
Phosphorylation and Functional Inactivation of TSC2 by Erk
c-IAP1 Cooperates with Myc by Acting as a Ubiquitin Ligase for Mad1
Presentation transcript:

NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN Xinjiang Wang, Lloyd C. Trotman, Theresa Koppie, Andrea Alimonti, Zhenbang Chen, Zhonghua Gao, Junru Wang, Hediye Erdjument- Bromage, Paul Tempst, Carlos Cordon-Cardo, Pier Paolo Pandolfi, Xuejun Jiang  Cell  Volume 128, Issue 1, Pages 129-139 (January 2007) DOI: 10.1016/j.cell.2006.11.039 Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 1 Polyubiquitination of PTEN In Vivo and In Vitro (A) Polyubiquitination of transfected PTEN. C-terminal His-tagged PTEN was cotransfected with HA-tagged ubiquitin (HA-Ub) in 293T cells as indicated. The cells were treated with or without 25 μM proteasome inhibitor MG132 for 6 hr and then harvested and lysed. His-tagged PTEN was pulled down with Ni2+ beads, washed with 6 M guanidine as described in Experimental Procedures, and subjected to immunoblotting against HA-tag to detect ubiquitinated PTEN. (B) In vitro ubiquitination of PTEN. The in vitro assay was performed as described in Experimental Procedures with individual components added as indicated. GST-PTEN was used as the substrate, and HS100 (5 μl and 5 mg protein/ml) was required to provide the PTEN ubiquitin ligase (E3) activity. Cell 2007 128, 129-139DOI: (10.1016/j.cell.2006.11.039) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 2 Purification and Identification of the PTEN E3 as NEDD4-1 (A) The purification scheme. The detailed procedure was described in Experimental Procedures. (B) The PTEN E3 activity in fractions (Fraction, 2 μl each) from the final Mono Q column was measured by the in vitro PTEN ubiquitination assay. (C) The final Mono Q fractions (15 μl each) were resolved by SDS-PAGE and stained with silver. (D) The purified PTEN E3 activity can ubiquitinate HA-tagged recombinant PTEN. The purified E3 (2 μl) or HS100 (5 μl) was used in the reactions as indicated. The ubiquitinated PTEN was detected by immunoblotting against HA-tag. (E) The domain structure of NEDD4-1. Amino acid positions of individual domains are denoted by corresponding numbers. (F) Interaction of NEDD4-1 with PTEN in 293T cells determined by coimmunoprecipitation analysis. PTEN and HA-tagged NEDD4-1 (N4-HA) were transfected as indicated. After immunoprecipitation using anti-HA antibody, PTEN and N4 were detected in the precipitates by immunoblotting (upper two panels). The cell lysate was blotted for N4, PTEN, and tubulin before immunoprecipitation (lower three panels) as a control. (G) Direct physical interaction of PTEN with NEDD4-1 (N4) determined by a GST pull-down assay. GST-PTEN but not GST alone pulled down purified NEDD4-1. Cell 2007 128, 129-139DOI: (10.1016/j.cell.2006.11.039) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 3 NEDD4-1 but Not NEDD4-2 Is an E3 for PTEN (A) NEDD4-1 but not NEDD4-2 was presented in the purified PTEN E3 fraction. Different volumes of HS100 (5 mg protein/ml) and purified PTEN E3 activity (E3) were subjected to immunoblot against NEDD4-1 and NEDD4-2 as indicated. (B) NEDD4-1 fractions but not NEDD4-2 fractions possess PTEN E3 activity. NEDD4-1 and NEDD4-2 in HS100 were separated by Mono Q chromatography as shown by immunoblotting (top panel). The PTEN E3 activity in 5 μl of individual fractions (fractions 13 and 14 as NEDD4-1 fractions; fractions 19 and 20 as NEDD4-2 fractions; fraction 11 as a negative control) was measured (bottom panel). Cell 2007 128, 129-139DOI: (10.1016/j.cell.2006.11.039) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 4 Regulation of PTEN Ubiquitination and Degradation by NEDD4-1 in Cells (A) Overexpression of NEDD4-1 enhances polyubiquitination of PTEN. His-tagged PTEN, HA-Ub, and an increasing amount of NEDD4-1 were cotransfected in 293T cells as indicated. The ubiquitination of His-tagged PTEN was detected as described in Figure 1A. The lower panel shows expression of NEDD4-1. (B) Overexpression of NEDD4-1 causes a decrease in PTEN protein level. As indicated, NEDD4-1 with a C-terminal HA-tag or vector alone was transfected in 293T cells by electroporation. After 24 hr, the cells were treated with or without 50 μM MG132 for 4 hr as indicated. Subsequently, the cells were harvested and lysed, and the endogenous PTEN levels of individual samples were detected by immunoblotting. β-tubulin was used as the loading control. PTEN levels (relative to tubulin) were quantitated by densitometry. (C) NEDD4-1 polyubiquitinates endogenous PTEN and targets it for proteasomal degradation. As described in Experimental Procedures, His-tagged ubiquitin and NEDD4-1-HA were transfected into 293T cells as indicated. The cells were treated with or without MG132 as indicated and then harvested and lysed. Proteins modified with His-tagged ubiquitin were pulled down and subjected to immunoblotting against PTEN. (D) RNAi of NEDD4-1. The efficacy of several human NEDD4-1 RNAi constructs (iN4A–iN4C) was examined by immunoblotting against HA-tag in HeLa cells that had been cotransfected with NEDD4-1-HA and RNAi constructs as indicated. A LacZ RNAi construct (iLacZ) was used as a control. (E) Elimination of NEDD4-1 by RNAi increases PTEN level in cells. Individual RNAi constructs were cotransfected into HeLa cells with PTEN-HA as indicated. The expressed PTEN-HA was detected by immunoblotting. (F) NEDD4-1 overexpression decreases PTEN stability. As detailed in Experimental Procedures, PTEN plasmid was cotransfected with NEDD4-1 or control plasmid as indicated. Cells were treated with cycloheximide and harvested at indicated time points. Subsequently, immunoblotting against PTEN, NEDD4-1 (both HA-tagged), and tubulin control was performed. (G) NEDD4-1 RNAi increases PTEN stability. PTEN was cotransfected with iN4A (NEDD4-1 RNAi) or control plasmid as indicated. Cells were treated with cycloheximide and harvested at indicated time points. Subsequently, immunoblotting against PTEN and tubulin control was performed. Cell 2007 128, 129-139DOI: (10.1016/j.cell.2006.11.039) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 5 NEDD4-1 Potentiates Cell Transformation in a PTEN-Dependent Manner (A) NEDD4-1 regulates AKT phosphorylation. RNAi plasmid iLacZ or iN4A was transfected into 293 cells by electroporation. Immunoblotting against NEDD4-1, PTEN, phospho-AKT (p-Akt), total AKT, and β-tubulin was performed as indicated. (B) Overexpression of NEDD4-1 in p53−/− primary MEFs decreased endogenous PTEN level. The MEFs were transfected with vector control or NEDD4-1 (N4-HA) as indicated by electroporation. The cells were lysed 24 hr later. N4-HA and endogenous PTEN were detected by immunoblotting. β-tubulin was blotted as the loading control. (C) Overexpression of NEDD4-1 promotes Ras-induced cell transformation in p53−/− primary MEFs. The p53−/− primary MEFs were infected with retroviruses encoding for no ectopic protein (vector), Ras, and/or NEDD4-1 (N4), as indicated. Soft-agar colony-formation assays were performed as described in Experimental Procedures. The pictures show the typical colony-formation assay result. (D) Overexpression of NEDD4-1 promotes cell transformation in a PTEN-dependent manner. The colony-formation assays were performed in both p53−/− primary MEFs and p53+/−Pten−/− primary MEFs. The plot represents the results from three independent experiments with standard deviation. Cell 2007 128, 129-139DOI: (10.1016/j.cell.2006.11.039) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 6 Reverse Correlation of NEDD4-1 and PTEN Levels in Cancer Samples (A) High levels of NEDD4-1 inversely correlate with a further decrease of PTEN levels in a mouse prostate cancer model. The panel shows a typical result of PTEN, NEDD4-1 (N4), and p-Akt IHC staining of Ptenhy/− mouse prostate tissues. The IHC shows that high NEDD4-1 expression levels always correlate with low PTEN levels that in turn correspond with high p-Akt and prostate-tumor initiation (p value < 0.001; calculated by chi-square test). Glands with tumor (tm) and normal glands (nl) are indicated. (B) The mRNA levels of NEDD4-1 and PTEN in a cohort of 87 invasive human bladder cancer samples. The mRNA levels were measured using Affymetrix GeneChip Plus 2.0. (C) Reverse correlation of NEDD4-1 mRNA levels with PTEN protein levels in the human bladder cancer samples. The 87 samples were classified into two groups (low NEDD4-1, 40 samples; and high NEDD4-1, 47 samples) based on the NEDD4-1 mRNA level of each sample relative to the mean NEDD4-1 mRNA value of the whole cohort. Then the PTEN-IHC status of the two groups was plotted. The inverse correlation of NEDD4-1 mRNA levels with PTEN protein levels in these samples is statistically significant with a p value of 0.04 calculated by both chi-square and Mann-Whitney tests. Cell 2007 128, 129-139DOI: (10.1016/j.cell.2006.11.039) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 7 NEDD4-1 RNAi Inhibited Xenotransplanted Tumor Growth in a PTEN-Dependent Manner (A) The human prostate cancer cell lines, DU-145 (PTEN-positive) and PC3 (PTEN-negative), were stably infected with NEDD4-1 RNAi and the control LacZ RNAi retroviruses. The infected cells were subcutaneously injected into athymic nude mice and the xenotransplanted tumor growth was measured as described in Experimental Procedures. (B) A model for the potential function of NEDD4-1 in prostate tumorigenesis. After loss of one allele of PTEN, aberrant upregulation of NEDD4-1 function will further decrease PTEN protein level and thus accelerate cancer development. Upregulation of NEDD4-1 might lead to malignancy more rapidly than a complete loss of PTEN gene because the latter will trigger INK4a- and p53-dependent senescence (Chen et al., 2005). NEDD4-1 offers a new entry point for therapeutic intervention that could arrest tumorigenesis in cooperation with the senescence response. Cell 2007 128, 129-139DOI: (10.1016/j.cell.2006.11.039) Copyright © 2007 Elsevier Inc. Terms and Conditions